# Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD

> **NCT00486772** · PHASE4 · COMPLETED · sponsor: **Gulhane School of Medicine**

## Conditions studied

- Vascular Diseases

## Interventions

- **DRUG:** Sevelamer (Renagel), calcium acetate (Phos-ex)

## Key facts

- **NCT ID:** NCT00486772
- **Lead sponsor:** Gulhane School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00486772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00486772, "Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00486772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*